Jeil Pharmaceutical Co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 20,156.79 million compared to KRW 799.69 million a year ago. Net income was KRW 12,702.53 million compared to net loss of KRW 3,921.05 million a year ago.

Basic earnings per share from continuing operations was KRW 872 compared to basic loss per share from continuing operations of KRW 269 a year ago. Basic earnings per share was KRW 872 compared to basic loss per share of KRW 269 a year ago.